These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8082583)

  • 1. Human exposure monitoring, dosimetry, and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA.
    Poirier MC
    Drug Metab Rev; 1994; 26(1-2):87-109. PubMed ID: 8082583
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: applications for detection of xenobiotics in biological samples.
    Poirier MC
    Mutat Res; 1993 Jul; 288(1):31-8. PubMed ID: 7686263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts.
    Weston A; Willey JC; Manchester DK; Wilson VL; Brooks BR; Choi JS; Poirier MC; Trivers GE; Newman MJ; Mann DL
    IARC Sci Publ; 1988; (89):181-9. PubMed ID: 3143667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of carcinogen-DNA adducts by immunoassay.
    Poirier MC; Liou SH; Reed E; Strickland PT; Tockman MS
    J UOEH; 1989 Mar; 11 Suppl():353-67. PubMed ID: 2664949
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl.
    Roberts DW; Benson RW; Groopman JD; Flammang TJ; Nagle WA; Moss AJ; Kadlubar FF
    Cancer Res; 1988 Nov; 48(22):6336-42. PubMed ID: 3180051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA adduct determination in humans.
    Poirier MC; Weston A
    Prog Clin Biol Res; 1991; 372():205-18. PubMed ID: 1956919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
    Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
    Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen-DNA adducts in human breast tissue.
    Perera FP; Estabrook A; Hewer A; Channing K; Rundle A; Mooney LA; Whyatt R; Phillips DH
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):233-8. PubMed ID: 7606197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adducts as markers of exposure and risk.
    Phillips DH
    Mutat Res; 2005 Sep; 577(1-2):284-92. PubMed ID: 15922369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung.
    Wiencke JK; Kelsey KT; Varkonyi A; Semey K; Wain JC; Mark E; Christiani DC
    Cancer Res; 1995 Nov; 55(21):4910-4. PubMed ID: 7585529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological methods for detection of carcinogen-DNA damage in humans.
    Santella RM
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):733-9. PubMed ID: 10498391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better perspectives on use of biological markers in monitoring of lung cancer risk in occupational settings.
    Jedrychowski W; Maugeri U; Bianchi I
    G Ital Med Lav; 1993; 15(5-6):99-104. PubMed ID: 7615181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
    Tierney B; Benson A; Garner RC
    J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.